We will probably submit our IL-17 paper next week – so it was of interest to read a new paper in NJ that
demonstrate a protective function for IL-17 and identify T cells as not only the source but also a target of IL-17 in vivo
for inflammatory bowel disease. Asthma may, however, present a different situation.
